Overview

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2028-05-31

Target enrollment:

Participant gender:

Summary

This is a randomized, controlled, phase II/III clinical study to evaluate the efficacy and safety of stand-of-care systemic therapy with local therapy versus stand-of-care systemic therapy in patients with oligoprogressive non-small cell lung cancer(NSCLC).

Phase:

PHASE2

Details

Lead Sponsor:

Shanghai Chest Hospital

Treatments:

Radiotherapy
Surgical Procedures, Operative